Trial
NCT02924389
Dolutegravir in Reservoirs
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
HIV
Intervention
dolutegravir
Why stopped
This study terminated early due to the ongoing covid-19 pandemic making it unsafe to recruit participants for in-person visits. Participants are living with HIV who are antiretroviral therapy-naive and are at high risk of COVID-19 complications.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-29